Details of Protein
General Information of Protein (ID: PRT00630) | |||||
---|---|---|---|---|---|
Name | Solute carrier family 13 member 3 (SLC13A3) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Na(+)/dicarboxylate cotransporter 3; NaDC-3; hNaDC3; Sodium-dependent high-affinity dicarboxylate transporter 2; SLC13A3; NADC3; SDCT2
|
||||
Gene Name | SLC13A3 | Gene ID | |||
UniProt ID | |||||
Family | Divalent anion:Na symporter (DASS) | ||||
TC Number | TC: 2.A.47.1.15 (Click to Show/Hide the Complete TC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MAALAAAAKKVWSARRLLVLLFTPLALLPVVFALPPKEGRCLFVILLMAVYWCTEALPLS
VTALLPIVLFPFMGILPSNKVCPQYFLDTNFLFLSGLIMASAIEEWNLHRRIALKILMLV GVQPARLILGMMVTTSFLSMWLSNTASTAMMLPIANAILKSLFGQKEVRKDPSQESEENT AAVRRNGLHTVPTEMQFLASTEAKDHPGETEVPLDLPADSRKEDEYRRNIWKGFLISIPY SASIGGTATLTGTAPNLILLGQLKSFFPQCDVVNFGSWFIFAFPLMLLFLLAGWLWISFL YGGLSFRGWRKNKSEIRTNAEDRARAVIREEYQNLGPIKFAEQAVFILFCMFAILLFTRD PKFIPGWASLFNPGFLSDAVTGVAIVTILFFFPSQRPSLKWWFDFKAPNTETEPLLTWKK AQETVPWNIILLLGGGFAMAKGCEESGLSVWIGGQLHPLENVPPALAVLLITVVIAFFTE FASNTATIIIFLPVLAELAIRLRVHPLYLMIPGTVGCSFAFMLPVSTPPNSIAFASGHLL VKDMVRTGLLMNLMGVLLLSLAMNTWAQTIFQLGTFPDWADMYSVNVTALPPTLANDTFR TL |
||||
Function | High-affinity sodium-dicarboxylate cotransporter that accepts a range of substrates with 4-6 carbon atoms, including succinate, alpha-ketoglutarate and N-acetylaspartate. The stoichiometry is probably 3 Na(+) for 1 divalent succinate. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic acids and derivatives | ||||||
N-Acetyl-L-aspartic acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Ala254Asp) of SLC13A3 | |||||
Induced Change | N-Acetyl-L-aspartic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Ala254Asp) of SLC13A3 leads to the decrease of N-acetyl-L-aspartic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Gly548Ser) of SLC13A3 | |||||
Induced Change | N-Acetyl-L-aspartic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Gly548Ser) of SLC13A3 leads to the decrease of N-acetyl-L-aspartic acid levels compared with control group. | |||||
Oxoglutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Ala254Asp) of SLC13A3 | |||||
Induced Change | Oxoglutaric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Ala254Asp) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Gly548Ser) of SLC13A3 | |||||
Induced Change | Oxoglutaric acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Gly548Ser) of SLC13A3 leads to the decrease of oxoglutaric acid levels compared with control group. | |||||
Succinic acid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Ala254Asp) of SLC13A3 | |||||
Induced Change | Succinic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Ala254Asp) of SLC13A3 leads to the decrease of succinic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (Gly548Ser) of SLC13A3 | |||||
Induced Change | Succinic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (Gly548Ser) of SLC13A3 leads to the decrease of succinic acid levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | SLC13A3 variants cause acute reversible leukoencephalopathy and -ketoglutarate accumulation. Ann Neurol. 2019 Mar;85(3):385-395. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.